Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

BACKGROUND: Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (LMWH) and mortality among COVID-19 hospitali...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Paolisso, Pasquale, Bergamaschi, Luca, D’Angelo, Emanuela Concetta, Donati, Francesco, Giannella, Maddalena, Tedeschi, Sara, Pascale, Renato, Bartoletti, Michele, Tesini, Giulia, Biffi, Mauro, Cosmi, Benilde, Pizzi, Carmine, Viale, Pierluigi, Galié, Nazzareno
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7424043/
https://ncbi.nlm.nih.gov/pubmed/32848743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01124
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki